ADMA Biologics
ADMA
ADMA
367 hedge funds and large institutions have $3.84B invested in ADMA Biologics in 2025 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 152 increasing their positions, 107 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.55% more ownership
Funds ownership: 86.83% → 88.37% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
6% less capital invested
Capital invested by funds: $4.08B → $3.84B (-$236M)
Holders
367
Holding in Top 10
6
Calls
$53M
Puts
$31.2M
Top Buyers
| 1 | +$82.4M | |
| 2 | +$32.8M | |
| 3 | +$30.4M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$26.5M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$19.8M |
Top Sellers
| 1 | -$53.8M | |
| 2 | -$28.3M | |
| 3 | -$27.2M | |
| 4 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$22M |
| 5 |
Two Sigma Investments
New York
|
-$19.2M |
